What is Dobataf 3 Tablet used for?
›Dobataf 3 Tablet is used to treat HIV-1 infection in adults and adolescents as a complete once-daily antiretroviral therapy (ART) regimen. It contains Dolutegravir (50mg), Emtricitabine (200mg) and Tenofovir Alafenamide (25mg), which work together to suppress HIV-1 viral load, raise CD4 cell count, and slow disease progression.
What is the recommended dosage of Dobataf 3 Tablet?
›The recommended dose is one Dobataf 3 Tablet once daily, taken at the same time each day, with or without food. Always follow your doctor’s prescribed dosage — never skip doses, as this increases the risk of HIV-1 drug resistance.
Can Dobataf 3 Tablet cure HIV?
›No. Dobataf 3 Tablet does not cure HIV infection. It helps control HIV-1 viral load, improves CD4 cell count, and prevents the disease from progressing to AIDS — but must be taken continuously as prescribed by your doctor.
What should I do if I miss a dose of Dobataf 3 Tablet?
›If you miss a dose, take it as soon as you remember on the same day. If it is close to the time for your next dose, skip the missed dose and continue your regular schedule — never take a double dose to make up for a missed one. Repeatedly missing doses can cause HIV-1 viral rebound and drug resistance, so set a daily reminder.
Does Dobataf 3 Tablet interact with other medicines?
›Yes. Inform your doctor about all medicines and supplements you take. Important interactions include antacids, multivitamins or supplements containing aluminium, magnesium, calcium, iron or zinc (take Dobataf 3 at least 2 hours before or 6 hours after these); rifampicin and anti-seizure medicines such as carbamazepine, which can reduce its effectiveness; St. John’s Wort; and metformin, whose levels may increase. Never start or stop any medicine without medical advice.
How long does Dobataf 3 Tablet take to work?
›Dobataf 3 begins lowering HIV-1 viral load within the first few weeks of treatment. Many people reach an undetectable viral load within 3–6 months of consistent daily use, alongside a steady rise in CD4 count. Regular viral load and CD4 monitoring confirms treatment effectiveness.
Does Dobataf 3 Tablet cause weight gain?
›Some people may experience weight gain with integrase-inhibitor regimens like Dobataf 3. This is usually manageable with a balanced diet and regular exercise. Discuss any significant or rapid weight change with your doctor, who can monitor your overall metabolic health.
Is Dobataf 3 Tablet safe for the kidneys and bones?
›Dobataf 3 contains Tenofovir Alafenamide (TAF), a newer form of tenofovir designed to be gentler on the kidneys and bones than older tenofovir (TDF). Even so, your doctor may monitor kidney function and bone health periodically, especially if you have existing kidney disease or risk factors. Inform your doctor of any kidney problems before starting.
Can pregnant or breastfeeding women take Dobataf 3 Tablet?
›Use during pregnancy should be decided only by your doctor after weighing the benefits and risks. Women living with HIV are generally advised not to breastfeed, as HIV can pass to the baby through breast milk. If you are pregnant, planning a pregnancy, or breastfeeding, consult your doctor before taking Dobataf 3.
Who should avoid taking Dobataf 3 Tablet?
›Dobataf 3 Tablet may not be suitable for people allergic to Dolutegravir, Emtricitabine or Tenofovir Alafenamide, those with significant kidney or liver impairment, or those taking medicines that strongly interact with it. Always share your complete medical history and current medications with your doctor before starting treatment.